What does BAYAT - ADLJU Société médicale do?

BAYAT - ADLJU Société médicale is a specialist medical practice in Welkenraedt. Private Limited, started on 21 April 2006, 1 establishment.

What is the address of BAYAT - ADLJU Société médicale?

The registered office of BAYAT - ADLJU Société médicale is located at Rue des Déportés 3, 4840 Welkenraedt.

Is BAYAT - ADLJU Société médicale still active?

Yes. According to the CBE (18 September 2026) BAYAT - ADLJU Société médicale is active, legal situation “Normale toestand”, started on 21 April 2006.

Is BAYAT - ADLJU Société médicale registered on Peppol?

Yes, BAYAT - ADLJU Société médicale is registered on the Peppol network with ID 0208:0880854327.

What is the enterprise number of BAYAT - ADLJU Société médicale?

The enterprise number of BAYAT - ADLJU Société médicale is BE0880854327.

When was BAYAT - ADLJU Société médicale founded?

BAYAT - ADLJU Société médicale was founded on 21 April 2006.

Who are the directors of BAYAT - ADLJU Société médicale?

According to the 2024 annual accounts, the directors of BAYAT - ADLJU Société médicale are: ARSALAN ADLJU, MOKHTARI SOUDABEH BAYAT.

Is BAYAT - ADLJU Société médicale a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 21 April 2006; 4 annual accounts filed, latest fiscal year 2024; 2 directors known from the annual account.

How much profit did BAYAT - ADLJU Société médicale make in 2024?

BAYAT - ADLJU Société médicale posted a profit after taxes of € 66,448 in financial year 2024.

What is the revenue of BAYAT - ADLJU Société médicale?

As a small company, BAYAT - ADLJU Société médicale is not required to publish revenue in its annual accounts. In financial year 2024, its added value was € 172,507.

BAYAT - ADLJU Société médicale (Private Limited)

Dossier BAYAT - ADLJU Société médicale, printed on 18 September 2026 from databakkes.be/en/0880854327/bayat-adlju-societe-medicale. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Warning lights

Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.

Tight liquidity NBB

Cash and receivables cover 54 % of short-term debt in 2024; threshold 65 %.

Financials

Financial year 2024

BAYAT - ADLJU Société médicale from Welkenraedt, company number BE0880854327, closed financial year 2024 with a result of € 66,448 after tax. For that financial year BAYAT - ADLJU Société médicale recorded a gross margin of € 172,507 and equity of € 400,591. Compared with financial year 2023, the result moved from € 79,991 to € 66,448. The company is profitable. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on July 16, 2025.

What it is worth Growing

€ 400,591

▲ 3% vs 2023

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Healthy

€ 66,448

▼ 17% vs 2023

Profit after tax over the fiscal year.

Cash in the bank

€ 115,974

▲ 51% vs 2023

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 53,000 paid out

80 % of the profit went to the shareholders, the rest stayed in the company.

People and assets in 2024

Vehicles and equipment

€ 38,088

▼ 44% vs 2023

Book value of vehicles, furniture and equipment.

Debts at end 2024

Bank debt ≈ 3 years to go The accounts give the long-term loan and the part due within the year. The remainder divided by that part is the number of years at an equal pace; a new loan or early repayment changes it.

€ 215,717

▼ 18% vs 2023

€ 70,557 is repaid this year. At this pace the long-term loan is gone in ≈ 3 years.

Owed to suppliers

€ 1,640

▲ 77% vs 2023

Supplier invoices still open on the last day of the fiscal year.

Taxes

€ 57,987

▼ 40% vs 2023

Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.

Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →

Key figures per fiscal year Download key figures (CSV)
	2021	2022	2023	2024	Change 2023 → 2024
Gross margin	€ 201,123 Gross margin 2021: € 201,123 First fiscal year in the series	€ 170,431 Gross margin 2022: € 170,431 ▼ 15% vs 2021 (€ 201,123) Unfavourable step	€ 178,336 Gross margin 2023: € 178,336 ▲ 5% vs 2022 (€ 170,431) Favourable step	€ 172,507 Gross margin 2024: € 172,507 ▼ 3% vs 2023 (€ 178,336) Unfavourable step	▼ 3%
Profit after taxes	€ 109,265 Profit after taxes 2021: € 109,265 First fiscal year in the series	€ 88,781 Profit after taxes 2022: € 88,781 ▼ 19% vs 2021 (€ 109,265) Unfavourable step	€ 79,991 Profit after taxes 2023: € 79,991 ▼ 10% vs 2022 (€ 88,781) Unfavourable step	€ 66,448 Profit after taxes 2024: € 66,448 ▼ 17% vs 2023 (€ 79,991) Unfavourable step	▼ 17%
Equity	€ 284,370 Equity 2021: € 284,370 First fiscal year in the series	€ 364,152 Equity 2022: € 364,152 ▲ 28% vs 2021 (€ 284,370) Favourable step	€ 387,143 Equity 2023: € 387,143 ▲ 6% vs 2022 (€ 364,152) Favourable step	€ 400,591 Equity 2024: € 400,591 ▲ 3% vs 2023 (€ 387,143) Favourable step	▲ 3%
Total debts	€ 393,753 Total debts 2021: € 393,753 First fiscal year in the series	€ 414,077 Total debts 2022: € 414,077 ▲ 5% vs 2021 (€ 393,753) Unfavourable step	€ 435,931 Total debts 2023: € 435,931 ▲ 5% vs 2022 (€ 414,077) Unfavourable step	€ 360,414 Total debts 2024: € 360,414 ▼ 17% vs 2023 (€ 435,931) Favourable step	▼ 17%
Cash	€ 77,020 Cash 2021: € 77,020 First fiscal year in the series	€ 133,554 Cash 2022: € 133,554 ▲ 73% vs 2021 (€ 77,020) Favourable step	€ 76,886 Cash 2023: € 76,886 ▼ 42% vs 2022 (€ 133,554) Unfavourable step	€ 115,974 Cash 2024: € 115,974 ▲ 51% vs 2023 (€ 76,886) Favourable step	▲ 51%
Land & buildings	€ 492,086 Land & buildings 2021: € 492,086 First fiscal year in the series	€ 474,108 Land & buildings 2022: € 474,108 ▼ 4% vs 2021 (€ 492,086) Unchanged	€ 456,131 Land & buildings 2023: € 456,131 ▼ 4% vs 2022 (€ 474,108) Unchanged	€ 438,153 Land & buildings 2024: € 438,153 ▼ 4% vs 2023 (€ 456,131) Unchanged	▼ 4%
Retained profit	€ 276,370 Retained profit 2021: € 276,370 First fiscal year in the series	€ 356,152 Retained profit 2022: € 356,152 ▲ 29% vs 2021 (€ 276,370) Favourable step	€ 379,143 Retained profit 2023: € 379,143 ▲ 6% vs 2022 (€ 356,152) Favourable step	€ 392,591 Retained profit 2024: € 392,591 ▲ 4% vs 2023 (€ 379,143) Favourable step	▲ 4%
Dividend	€ 22,000 Dividend 2021: € 22,000 First fiscal year in the series	€ 9,000 Dividend 2022: € 9,000 ▼ 59% vs 2021 (€ 22,000) Unchanged	€ 57,000 Dividend 2023: € 57,000 ▲ € 48,000 vs 2022 (€ 9,000) Unchanged	€ 53,000 Dividend 2024: € 53,000 ▼ 7% vs 2023 (€ 57,000) Unchanged	▼ 7%
Bank debt	€ 279,391 Bank debt 2021: € 279,391 First fiscal year in the series	€ 268,620 Bank debt 2022: € 268,620 ▼ 4% vs 2021 (€ 279,391) Favourable step	€ 264,571 Bank debt 2023: € 264,571 ▼ 2% vs 2022 (€ 268,620) Favourable step	€ 215,717 Bank debt 2024: € 215,717 ▼ 18% vs 2023 (€ 264,571) Favourable step	▼ 18%
Balance sheet total	€ 678,124 Balance sheet total 2021: € 678,124 First fiscal year in the series	€ 778,229 Balance sheet total 2022: € 778,229 ▲ 15% vs 2021 (€ 678,124) Unchanged	€ 823,073 Balance sheet total 2023: € 823,073 ▲ 6% vs 2022 (€ 778,229) Unchanged	€ 761,005 Balance sheet total 2024: € 761,005 ▼ 8% vs 2023 (€ 823,073) Unchanged	▼ 8%

Key figures of BAYAT - ADLJU Société médicale, fiscal years 2021 to 2024, from the annual accounts filed with the National Bank of Belgium.The annual account for fiscal year 2025 has not been filed yet; it was expected before 31 July 2026.

What happened to BAYAT - ADLJU Société médicale?

What happened at BAYAT - ADLJU Société médicale in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Jul 16, 2025 New annual accounts for financial year 2024: profit of € 66,448 (▼ 17% vs 2023). Source: NBB ↗
Apr 21, 2006 New establishment in Welkenraedt. KBO
Apr 21, 2006 Start of the company according to the CBE. KBO

In short

From € 109,265 profit in 2021 to € 66,448 profit in 2024.

Paid € 170,865 in corporate taxes since 2021.

Best year ever: 2021, with € 109,265 profit.

Paid out € 141,000 in dividends to the owners in total.

Original PDFs at the National Bank ↗

A new publication or filing at BAYAT - ADLJU Société médicale? We notify you, reason included.

Follow BAYAT - ADLJU Société médicale

Databakkes Pro

Know what changes at your customers, suppliers and competitors. Without reading an annual account.

Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.

Yes, I want that

See what a followed company gets: the De Lijn dossier

Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.

My folder 3 companies

De Lijn 8 June 2026 New annual account 2025

filed on 8 June 2026

What was left

€ 20 k ▼ 91%
Money in the bank

€ 178 k ▼ 98%

Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit

Real filings at the National Bank

Management

ARSALAN ADLJU MOKHTARI SOUDABEH BAYAT

BAYAT - ADLJU Société médicale

Behind BAYAT - ADLJU Société médicale are ARSALAN ADLJU and MOKHTARI SOUDABEH BAYAT.

See the full network in the app

Directors

According to the 2024 annual accounts

ARSALAN ADLJU

Director

MOKHTARI SOUDABEH BAYAT

Director

Establishments

Establishment units

Physical locations of this company

Registered office

Rue des Déportés 3

4840 Welkenraedt

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number: 0880.854.327
VAT number: BE 0880.854.327
Registered office: Rue des Déportés 3, 4840 Welkenraedt
Names & denominations: BAYAT - ADLJU Société médicale
Enterprise type: Rechtspersoon
Legal form: Private limited company
Legal situation: Normale toestand
Start date: 21 April 2006
Peppol: Active · Active since 24 Nov 2025
Activities · NACE: Activiteiten van medisch specialisten

View on CBE Public ↗ Annual accounts (NBB) ↗